Pharmorubicin

DRUG3 trials

Sponsors

Jinling Hospital, China, Shengjing Hospital, Zhejiang Cancer Hospital

Conditions

0.5-14 Year Old Children With NephroblastomaGastric CancerPeripheral T Cell LymphomaStomach Neoplasms

Phase 2

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

Zhejiang Cancer HospitalPeripheral T Cell Lymphoma

Start: 2019-08-12End: 2021-12-05Target: 54Updated: 2019-08-20

Phase 3

Comparison of SEEOX and SOX Regimens in Stage ⅢB/ⅢC Gastric Cancer Patients

Jinling Hospital, ChinaGastric Cancer, Stomach Neoplasms

Start: 2015-01-04End: 2023-10-31Updated: 2023-09-29

Phase 4

Combination Therapy of Anthracyclines for Children With Nephroblastoma

Not yet recruitingNCT03892330

Shengjing Hospital0.5-14 Year Old Children With Nephroblastoma

Start: 2019-06-01End: 2045-06-30Target: 120Updated: 2019-03-27

Related Papers

The Combination of Bortezomib with Cyclophosphamide, Epirubicin, Etoposide and Prednisone (BCHEP) Regimen As First-Line Treatment for Untreated Patients with Peripheral T Cell Lymphoma: A Prospective, Single Arm, Phase II Study

Blood2021-11-051 citations